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ABSTRACT
Objective: The objective of this selective EBM review is to determine whether or not the use of
dry needling in one or more active myofascial trigger points in the trapezius muscle is effective
in decreasing pain in adults.
Study Design: Review of three randomized control trials.
Data Sources: All articles were published in English between 2014 and 2016. Articles were
obtained from peer-reviewed journals and databases using Cochrane Collaboration and PubMed.
Outcomes: The outcome measured was level of pain using the Visual Analogue Scale (VAS).
The VAS asked participants to rate their pain on a scale of 0 (no pain) to 10 (maximal pain).
Results: Ziaeifar et al. (J Bodyw Mov Ther. 2014;18(2):298-305. doi:
//doi.org/10.1016/j.jbmt.2013.11.004) proved that dry needling MTrPs in the upper trapezius
muscle was effective in decreasing subjective pain intensity (P=0.000) and was significantly
better at doing so than a trigger point compression technique on MTrPs (P=0.01). Cerezo-Tellez
et al. (J Man Manip Ther. 2016;24(4):223-32. doi: 10.1179/2042618615Y.0000000004) revealed
dry needling on top of stretching was effective in decreasing pain (P < 0.05) and was
significantly more successful than passive stretching alone (P<0.05). Finally, Pecos-Martin et al.
(Arch Phys Med Rehabil. 2015;96(5):775-781. doi: 10.1016/j.apmr.2014.12.016) found dry
needling on an MTrP had a significantly greater decrease in pain intensity than dry needling 1.5
cm medially to an MTrP at both 1-week and 1-month post-treatment (P < 0.05).
Conclusions: All three articles in this evidence-based review demonstrated that the use of dry
needling in one or more active MTrPs in the trapezius muscle is effective in decreasing pain in
adults. Further, dry needling MTrPs was significantly more successful in decreasing pain than a
trigger point compression technique of MTrPs, stretching, or dry needling 1.5 cm away from the
MTrP. Future studies should include a broader age population, investigate the number of dry
needling treatments needed for pain reduction, and explore the use of dry needling MTrPs in
more than one muscle at a time.
Keywords: dry needling, neck pain, myofascial pain syndrome, trapezius

INTRODUCTION
Musculoskeletal pain is the most common cause of disability globally.1 It can be caused
by injury, overuse mechanisms, underlying medical disorders, or be idiopathic. Despite the
different etiologies of pain, many patients share the unfortunate experience of persistent pain and
a decreased quality of life. Musculoskeletal pain occurs in over 50% of individuals above 18
years old and nearly 75% of individuals 65 years and older.2 Annually, approximately 85% of
musculoskeletal patients will have at least one healthcare visit, with the average number of visits
per person being just under six.3 In 2011, musculoskeletal pain accounted for 18% of healthcare
visits.2 These numbers are putting an increased demand on the workload of physicians. Physician
assistants have the ability to work with physicians to evaluate, diagnose and treat patients with
musculoskeletal conditions.
Musculoskeletal pain does not only put a large demand on physician workload, but also
puts an increased financial burden on the healthcare system. This is due to both direct expenses
on healthcare management and indirect losses from decreased productivity.1 In 2011
musculoskeletal pain cost the United States $213 billion, which accounts for 1.4% of its Gross
Domestic Product (GDP).2 When patients with both musculoskeletal pain and other comorbid
conditions are included, costs rise to $874 billion, or 5.7% of GDP. 3 This price is higher than
that of heart disease, cancer, and diabetes in the United States.4
Although the basic mechanisms behind musculoskeletal pain are largely understood,
researchers have yet to find a definitive treatment for patients. Currently, musculoskeletal pain is
managed by a variety of treatments. Treatment options include exercise therapy, manual therapy,
psychosocial intervention, acupuncture, analgesics, NSAIDS, corticosteroid injections, or
surgical interventions.1 These treatments have shown some efficacy in improving
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musculoskeletal pain; however, many patients exhaust their options without finding a definitive,
long-term treatment.
Over the past decade, researchers have explored the role of myofascial trigger points
(MTrPs) in musculoskeletal pain and discovered that MTrPs are one of the primary causes of
pain. MTrPs are hypersensitive spots in taut bands of skeletal muscles that produce local and/or
referred pain when palpated or compressed.5 Dry needling is a newer treatment that involves
rapidly moving a tube-guided acupuncture needle in and out of an MTrP.6 It has shown
promising efficacy in relieving musculoskeletal pain both immediately and long term.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not the use of dry
needling in one or more active myofascial trigger points in the trapezius muscle is effective in
decreasing pain in adults.
METHODS
The studies used in this review were found by searching Cochrane Collaboration and
PubMed databases with the keywords “dry needling”, “neck pain”, “myofascial pain syndrome”,
and “trapezius”. Studies were chosen for this review if they proved relevance to the clinical
topic, results were measured by Patient-Oriented Evidence that Matters (POEMs) and fit the
inclusion and exclusion criteria for this study. Inclusion criteria consisted of randomized control
trials published after 2009. Exclusion criteria consisted of studies containing patients under 18
years old. Table 1 presents further inclusion and exclusion criteria for the individual studies
included in this review as well as additional components of each study. Ultimately, three
randomized control trials were selected for this review. All of the studies selected were written in
English and published in peer-reviewed journals.
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The population being studied in this review is patients over 18 years old with pain. The
intervention applied in all three studies was dry needling active MTrPs in the trapezius muscle.
Each study used a different comparison group. Ziaeifar et al. used trigger point compression
technique (TCT) on a MTrP, while Cerezo-Tellez et al. used passive stretching and Pecos-Martin
et al. used dry needling 1.5 centimeters medially from a MTrP.7,8,9 The outcome measured in all
of the studies was improvement in the patient’s pain based on a decrease in their subjective pain
intensity. Subjective pain intensity was measured using the Visual Analogue Scale (VAS).
Statistical significance for each study was reported using p-values.

OUTCOMES MEASURED
The major outcome measured in all three studies focused on decreasing subjective pain
intensity for patients. Subjective pain intensity was assessed using the Visual Analogue Scale
(VAS). The VAS is a continuous scale on a horizontal line with markings of 0 and 10 on the
ends of the line. The 0 on one end indicates the patient is not experiencing pain and 10 on the
other end indicates the patient is experiencing maximal pain. The scale does not include
intermediate descriptors in order to avoid clustering of response around certain preferred
numbers.10 At each time of desired assessment for pain, patients were asked to place one vertical
line on the scale corresponding to their subjective level of pain.
RESULTS
Ziaeifar et al. (2014) conducted a randomized control trial comparing the standard use of
trigger point compression technique (TCT) on MTrPs to the experimental use of dry needling
MTrPs in the upper trapezius muscle.7 The population of the study included a convenience
sample of patients aged 20-48 who had active MTrPs in the upper trapezius muscle and were
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referred for outpatient physical therapy.7 Further inclusion and exclusion criteria for the study
can be found in Table 1.
Table 1 – Demographics & Characteristics of Included Studies
Study

Type #
Age
Inclusion
Pts (yrs) Criteria
RCT 33 20-48 Patients with
active MTrP in
the upper
trapezius
muscle and who
were referred
for OP PT
evaluation &
intervention.

Exclusion Criteria

W/D Interventions

Patients with a history of
fibromyalgia, whiplash,
cervical spine surgery &
fracture, cervical
radiculopathy, MTrP
therapy within 1 month,
diagnosis of a systematic
disease (rheumatism,
tuberculosis, cervical
myelopathy, multiple
sclerosis), or a
contraindication for
needling (local infection,
pregnancy with
threatened abortion,
taking anticoagulants).

0

Dry needling
VS. Trigger
point
compression
technique on
MTrPs

CerezoTellez8
(2016)

RCT

44

>18

0

Dry needling
and passive
stretching VS.
Passive
stretching
only

PecosMartin9
(2015)

RCT

72

18-42 Patients with
unilateral neck
pain for 3 or
more months
and 1 or more
active MTrPs in
the lower
trapezius
muscle.

Patients using antiinflammatory,
analgesics,
anticoagulants, muscle
relaxants or
antidepressants within 1
week, history of
fibromyalgia, or a
contraindication to
therapy (infection, fever,
fear of needles, cancer,
hypothyroidism, wounds
in puncture area, metal
allergy, systemic
disease).
Patients with a history of
neck trauma, cervical
radiculopathy, previous
neck or shoulder surgery,
diagnosed primary
headaches, or trigger
point therapy; MTrPDN within 6 months,
cognitive deficits, or
needle phobia.

0

Dry needling
on MTrP of
the lower
trapezius VS.
Dry needling
1.5 cm
medially from
a MTrP of the
lower
trapezius
muscle

Ziaeifar7
(2014)

Office workers
with neck pain
using a
computer
mouse >4
hours/day and 1
or more active
MTrPs in the
trapezius
muscle.
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Thirty-three patients were randomly assigned to the control TCT group (N= 17) or the
experimental dry needling group (N=16).7 Each group received three treatment sessions with one
off day in between each session.7 Pain intensity was measured using the VAS before and after
each treatment session as well as again two days after the third treatment session.7 All 33 patients
completed the study.7 A paired t-test used in the trial revealed that both TCT and dry needling
had statistically significant improvements in decreasing pain intensity (P<0.05) (Table 2).7 In
addition, the Analysis of Covariance (ANCOVA) was calculated and determined that there was a
significant difference between the TCT and dry needling groups on post-measurement scores
(P<0.05), indicating that the dry needling treatment made more of an impact in reducing pain
than the TCT treatment (Table 3).7
Table 2 – VAS scores expressed as mean ± SD before and after treatment7
Before treatment

After treatment

P-value

Experimental group

6.56 ± 1.63

1.34 ±1.93

0.000*

Control group

6.23 ± 1.26

3.05 ± 2.27

0.000*

*= Statistically significant (P < 0.05)
Table 3 – Change in pain intensity expressed as mean ± SD in experimental and control groups7

Change in pain
intensity

Experimental group

Control group

Between group
difference

P-value

5.21± 2.02

3.17 ± 2.43

2.04

0.01*

*= Statistically significant (P < 0.05)

Cerezo-Tellez et al. conducted a randomized, single-blinded, clinical trial on office
workers over 18 years old with neck pain, who used the computer mouse over four hours per
day.8 Further inclusion and exclusion criteria for the study can be found in Table 1. This study
equally and randomly split 44 patients into either the control group, consisting of passive
stretching, to the experimental group, which used dry needling MTrPs in the trapezius muscle on
top of passive stretching.8 Both groups completed five treatment sessions over three weeks.8 This
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included two sessions per week during the first two weeks, with three days between each session,
and one treatment session during the third week.8 Pain intensity was measured using the VAS at
baseline (day 0), post-intervention (day 30), and follow-up (day 45).8 If at some point during the
study patients no longer felt pain, intervention for that patient was discontinued, but pain
intensity was still measured as planned.8 All patients completed the study and the average
number of treatment sessions was three and five for the experimental and control groups
respectively.8 Wilcoxon tests revealed that both passive stretching alone and passive stretching
on top of dry needling were effective in decreasing pain (P<0.05) (Table 4); however, a MannWhitney U-test proved that dry needling with passive stretching was significantly more effective
in decreasing pain than passive stretching alone (P<0.05) (Table 5).8
Table 4 –VAS scores expressed as median (IQR) at baseline, post-intervention, and follow-up8
Treatment
group
Control
group

Baseline

Post-intervention

Follow-up
0 (0.3)

P- value
(post-intervention)
<0.001*

P-value
(follow-up)
<0.001*

5.8 (1)

0 (0.3)

5 (3)

3 (3.2)

3 2.2)

<0.001*

<0.001*

*= Statistically significant (P < 0.05)

Table 5 – Inter-group comparison of VAS scores expressed by p-values8
P-value
(baselines)
Treatment group
0.784
VS.
Control group
*= Statistically significant (P < 0.05)

P-value
(post-interventions)

P-value
(follow-ups)

<0.001*

<0.001*

Pecos-Martin et al. conducted a randomized, double-blinded controlled study on
individuals with mechanical idiopathic neck pain ages 18-42 years old.9 Additional inclusion and
exclusion criteria can be found in Table 1. Seventy-two patients were randomly and evenly split
into the control group or the treatment group.9 The experimental group received dry needling on
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an MTrP of the lower trapezius muscle, whereas the control group received dry needling 1.5-cm
medially from an MTrP of the lower trapezius muscle.9 Both groups received the same amount
of needle insertions during their treatment session, and pain intensity was measured using the
VAS before treatment as well as 1-week and 1- month after treatment.9 There were no dropouts
in this study.9 The mixed-model linear analysis demonstrated that dry needling 1.5-cm medially
from an MTrP was not effective, whereas dry needling on an MTrP was (P < 0.05) (Table 6).9
Hence, the treatment group had a significantly greater decrease in pain intensity as compared to
the control group at both 1-week and 1-month post-treatment (P < 0.05) (Table 7).9
Table 6 – VAS scores expressed as mean ± SD before treatment, 1-week post-treatment, and 1month post-treatment9
Before
treatment

1-week
post- treatment

Control
5.6 ± 1.6
5.3 ± 1.6
group
Treatment
5.3 ± 1.5
2.6 ± 1.8
group
*= Statistically significant (P < 0.001)

1-month
post- treatment

P-value
(1-week)

P-value
(1-month)

5.1 ± 1.5

>0.001

>0.001

2.1 ± 1.6

<0.001*

<0.001*

Table 7 – Change in intensity expressed as mean (95% confidence interval)9
Standard group
Change in pain
0.3 (-0.0 to 0.6)
intensity
(1-week)
Change in pain
0.5 (0.1-0.9)
intensity
(1-month)
*= Statistically significant (P < 0.001)

Experimental group
2.7 (2.0-3.3)

Between group
difference
2.4 (1.6-3.2)

P-value
P<.001*

3.2 (2.6-3.8)

2.7 (2.0-3.4)

P<.001*

DISCUSSION
Myofascial trigger points have proven to be one of the primary causes of musculoskeletal
pain, but their use in treatment of musculoskeletal pain is often overlooked because their
pathophysiology is not completely understood. It is hypothesized that MTrPs are formed during
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sub-maximal level muscle exertion with low- to- moderate physical loads.6 In these scenarios,
smaller muscle fibers are the first to be engaged and last to be disengaged resulting in continuous
activity, metabolic overload.6 Eventually, this strain can lead to calcium dysregulation, decreased
intramuscular perfusion, hypoxia and ischemia of the muscle.6 All of these imbalances are
thought to lead to the development of MTrPs, causing tenderness as well as localized and
referred pain.6 Dry needling MTrPs is thought to normalize chemical imbalances, release small
muscle fiber shortenings, and increase microcirculation to the area, resulting in pain relief.7
Dry needling is mainly used for its beneficial role in musculoskeletal pain; however,
researchers have also investigated its use in increasing flexibility as well as treating impingement
syndromes, tension headaches, and migraine headaches. Dry needling is practiced legally across
the United States by physicians, physician assistants, physical therapists, nurse practitioners, and
chiropractors. Although all of these providers are eligible to perform dry needling, the number of
medical professionals who do may be limited. This is because providers must complete a postgraduate continuing education course in order to be qualified to perform dry needling. Another
challenge with the use of dry needling is that it is not typically covered by insurance. Although
these issues limit the availability of dry needling, they are worth trying to overcome as dry
needling has proven to be an exceptionally promising option for decreasing musculoskeletal
pain.
All 3 studies in this review demonstrated that dry needling MTrPs in the trapezius muscle
was effective in decreasing subjective pain intensity in adults. Further, dry needling MTrPs
proved to be more effective than trigger point compression technique on MTrPs, passive
stretching and dry needling 1.5 centimeters medially from a MTrP in reducing pain intensity.7,8,9
One limitation that is consistent throughout these studies was the lack of generalizability to older
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adults. Although the studies included participants exclusively over the age of 18, they generally
consist of a younger population. The study by Ziaeifar et al. included patients age 20 to 48,
Cerezo-Tellez et al.’s participants had an average age of 43.6, and Pecos-Martin et al.’s
participants had an average age of 25.3.7,8,9 Another limitation to this review is that all three
studies had a different number of treatment sessions, making it difficult to determine how many
sessions are needed for dry needling to be effective both immediately and long-term. Ziaeifar et
al. included three treatment sessions, Cerezo-Tellez et al. included five, and Pecos-Martin et al.
included one.7,8,9 Finally, participants were not blinded in all three studies. Blinding was
achieved in the study by Pecos-Martin et al. because the control group involved dry needling and
participants were not able to distinguish between dry needling an MTrP and dry needling the
muscle itself.9 In contrast, it was clear to patients in the studies by Ziaeifar et al. and CerezoTellez et al. whether they were receiving dry needling treatment or the control treatment because
the control treatments in these studies did not involve dry needling.7,8 The participants’
subjective rating of pain after treatments may have been influenced by how they perceive the
effectiveness of their assigned treatment.
An area of concern for all three studies was that they did not address safety concerns.
Outside studies have reported that mild adverse reactions such as bruising, bleeding, pain during
and after treatment are common with dry needling treatments.11 Much less common but more
significant concerns that have been reported with dry needling are altered emotions, shaking,
nerve injury, vascular injury, pneumothorax, and infection.11,12
CONCLUSIONS
All three randomized control trials in this evidence-based review demonstrated that the
use of dry needling in one or more active MTrPs in the trapezius muscle is effective in
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decreasing pain in adults. In all three studies, dry needling MTrPs was significantly more
successful in decreasing pain than compression of MTrPs, stretching, or dry needling 1.5 cm
away from the MTrP.7,8,9
Future studies should use a broader age range including older adults, especially over the
age of 65, since a large majority of this population experiences musculoskeletal pain. Future
studies should also investigate the number of dry needling treatments needed to be effective as
well as any safety concerns or adverse reactions. Additionally, future studies should focus on
blinding participants to their treatment groups in order to increase the validity of their studies.
Finally, future studies should consider the efficacy of dry needling MTrPs in multiple muscle
groups at once. It is well understood that multiple cervical muscles contribute to neck pain, so
including more than one muscle in treatment may help further enhance the effects of dry
needling MTrPs in adults.
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